文献速递主动脉疾病

编辑推荐——在常规血管腔内主动脉瘤修复术中完全使用二氧化碳的可行性与安全性:多中心、前瞻性、零碘对比剂血管腔内动脉瘤修复研究结果

Editor's Choice - Feasibility and Safety of Using Carbon Dioxide Exclusively in Regular Endovascular Aortic Aneurysm Repair: Results of a Multicentre, Prospective, Zero Iodine Contrast Endovascular Aneurysm Repair Study.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2024-11-16

这项前瞻性多中心国家研究纳入2023年1月至2024年1月连续293例无症状腹主动脉瘤(≥55 mm)患者,评估仅用二氧化碳(CO2)造影完成标准血管腔内动脉瘤修复(EVAR)的可行性与安全性。零碘对比剂EVAR在240例(81.9%)中可行,30天死亡率为0.3%(n=1),CO2相关不良事件罕见(1%,n=3)且轻微。作者结论为该标准化零碘对比剂EVAR方案安全可行,适用于82%的连续非选择患者。

要点

  • 零碘对比剂EVAR在240例(81.9%)连续患者中可行,30天死亡率为0.3%(n=1)。
  • CO2相关不良事件罕见(1%,n=3)且轻微。
  • 动脉瘤直径>70 mm和最低肾动脉位于3至9点方向是使用碘对比剂的显著预测因素。

核心结论

  • 本研究报告的标准化零碘对比剂EVAR方案安全可行,适用于82%的连续非选择患者。
  • 局限性主要来自解剖因素,辅助标准化操作可在多数情况下有效应对这些挑战。

研究设计与样本

  • 前瞻性、多中心、全国性研究,2023年1月至2024年1月连续纳入无症状腹主动脉瘤≥55 mm且标准腔内移植物(按说明书)解剖可行的患者。
  • 共纳入293例患者(10个中心),中位年龄78岁(四分位距72,83),男性256例(87.4%)。
  • 术中使用自动CO2注射器标准化术中成像,并设计五步标准化策略以显示首次CO2造影未可见的目标血管。

主要发现

  • 总体手术时间、透视时间和注入CO2体积分别为90分钟(四分位距65,125)、15分钟(四分位距10,22)和600 mL(四分位距400,800)。
  • 30天死亡率、并发症率和再干预率分别为0.3%(n=1)、6.8%(n=20)和2.4%(n=7)。
  • CO2相关不良事件罕见(1%,n=3)且轻微。
  • 零碘对比剂EVAR在240例患者(81.9%)中可行。
  • 五步标准化操作使用情况:步骤A 170例(58.0%)、步骤B 109例(37.2%)、步骤C 21例(7.2%)、步骤D 14例(4.8%)、步骤E 53例(18.1%),步骤E中位碘对比剂体积为20 mL(四分位距10,35)。

临床怎么用

  • 作者结论认为该标准化零碘对比剂EVAR方案安全可行,适用于82%的连续非选择患者。
  • 作者指出局限性主要来自解剖因素,辅助标准化操作可在多数情况下有效应对这些挑战。

局限性

  • 局限性主要来自解剖因素,辅助标准化操作可在多数情况下有效应对这些挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Carbon dioxide (CO2) angiography has emerged as a viable alternative to regular iodinated contrast medium (ICM) for guiding endovascular aneurysm repair (EVAR) procedures. This study aimed to evaluate the feasibility and safety of a standardised EVAR procedure using only CO2 angiography. METHODS: A prospective, multicentre, national study enrolled consecutive patients between January 2023 and January 2024 with asymptomatic abdominal aortic aneurysms measuring ≥ 55 mm and for whom a standard endovascular graft (instructions for use) was anatomically feasible. The study involved the use of an automatic CO2 injector to standardise intra-operative imaging. A strategy comprising five standardised steps was devised to visualise a target vessel (TV) that could not be seen during the first CO2 angiogram. The five steps were: (A) place the introducer closer to the TV; (B) tilt the table by 5 - 10° in the direction opposite to the TV; (C) selectively cannulate the TV; (D) cannulate the contralateral gate (only for repositionable devices); CO2 angiography was repeated in steps 1 - 2; and (E) use ICM. RESULTS: Two hundred and ninety-three patients were enrolled (10 centres), with a median age of 78 (interquartile range [IQR] 72, 83) years; 256 (87.4%) were male. The overall procedure time, fluoroscopy time, and injected CO2 volume were 90 (IQR 65, 125) minutes, 15 (IQR 10, 22) minutes, and 600 (IQR 400, 800) mL, respectively. The 30 day mortality, complication, and re-intervention rates were 0.3% (n = 1), 6.8% (n = 20), and 2.4% (n = 7), respectively. CO2 related adverse events were rare (1%; n = 3) and minor. A zero iodine contrast EVAR procedure was feasible in 240 (patients 81.9%). The five standardised steps were used extensively: step A, 170 procedures (58.0%); step B, 109 procedures (37.2%); step C, 21 procedures (7.2%); step D, 14 procedures (4.8%); and step E, 53 procedures (18.1%), with a median volume of 20 (IQR 10, 35) mL. Significant predictors for ICM use were aneurysm diameter > 70 mm and a lowermost renal artery positioned between 3 and 9 o'clock. CONCLUSION: This study demonstrated that the standardised zero iodine contrast EVAR protocol reported here is both safe and feasible and is applicable in 82% of consecutive non-selected patients. Limitations primarily arose from anatomical factors, and adjunctive standardised manoeuvres can effectively address these challenges in most cases.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Chisci E, Ferrero E, Antonello M, et al. Editor's Choice - Feasibility and Safety of Using Carbon Dioxide Exclusively in Regular Endovascular Aortic Aneurysm Repair: Results of a Multicentre, Prospective, Zero Iodine Contrast Endovascular Aneurysm Repair Study. Eur J Vasc Endovasc Surg. 2024. PMID: 39557380. doi:10.1016/j.ejvs.2024.11.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。